Dr. Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals is interviewed by RedChip at NobleCon21 – Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL
TMS
Feb. 9, 2026
Dr. Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals interview by RedChip at NobleCon21 – Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference
Dec. 9, 2025
Dr. Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals presents at NobleCon21 – Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference
Dr. Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals presents at NobleCon21 – Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference
Nov. 21, 2025
Ending Veteran Suicide with Neuroplastic Therapies – NRx & Angel Force USA
Dr. Jonathan Javitt, CEO of NRx Pharmaceuticals, and Anne Dunsmore, Founder of Angel Force USA, discuss their joint mission to prevent veteran suicide through advanced neuroplastic therapies and nationwide awareness programs.